Varex Imaging Corporation
Varex Imaging Corporation (VREX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Varex Imaging Corporation (VREX), covering cash flow, earnings, and balance sheets.
Varex Imaging Corporation (VREX) Income Statement & Financial Overview
Analyze Varex Imaging Corporation’s VREX earnings with segmented quarterly and yearly financial statement figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $212.90M | $199.80M | $205.70M | $209.10M |
Cost of Revenue | $136.20M | $131.30M | $138.60M | $142.20M |
Gross Profit | $76.70M | $68.50M | $67.10M | $66.90M |
Gross Profit Ratio | $0.36 | $0.34 | $0.33 | $0.32 |
R&D Expenses | $22.00M | $23.50M | $21.90M | $22.00M |
SG&A Expenses | $32.60M | $33.80M | $34.30M | $35.60M |
Operating Expenses | $54.60M | $57.30M | $56.20M | $57.60M |
Total Costs & Expenses | $190.80M | $188.60M | $194.80M | $199.80M |
Interest Income | $2.90M | $2.10M | $1.80M | $1.80M |
Interest Expense | $10.40M | $8.20M | $7.80M | $7.60M |
Depreciation & Amortization | $6.60M | $7.10M | $6.60M | $7.00M |
EBITDA | $22.10M | $17.80M | $16.90M | $16.30M |
EBITDA Ratio | $0.10 | $0.09 | $0.08 | $0.08 |
Operating Income | $22.10M | $11.20M | $10.90M | $9.30M |
Operating Income Ratio | $0.10 | $0.06 | $0.05 | $0.04 |
Other Income/Expenses (Net) | -$11.30M | -$8.70M | -$8.40M | -$8.50M |
Income Before Tax | $10.80M | $2.50M | $2.50M | $800000.00 |
Income Before Tax Ratio | $0.05 | $0.01 | $0.01 | $0.004 |
Income Tax Expense | $3.70M | $2.60M | $52.40M | -$700000.00 |
Net Income | $6.90M | -$300000.00 | -$50.00M | $1.40M |
Net Income Ratio | $0.03 | -$0.002 | -$0.24 | $0.007 |
EPS | $0.17 | -$0.007 | -$1.23 | $0.03 |
Diluted EPS | $0.17 | -$0.007 | -$1.23 | $0.03 |
Weighted Avg Shares Outstanding | $41.40M | $41.10M | $40.80M | $40.90M |
Weighted Avg Shares Outstanding (Diluted) | $51.20M | $41.10M | $40.80M | $41.20M |
Over the past four quarters, Varex Imaging Corporation demonstrated steady revenue growth, increasing from $209.10M in Q3 2024 to $212.90M in Q2 2025. Operating income reached $22.10M in Q2 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $22.10M, reflecting operational efficiency. Net income rose to $6.90M, with EPS at $0.17. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan